The significance of quality of life in health care

Quality of Life Research

Volumn 12, Issue SUPPL. 1, 2003, Pages 3-16

  Kaplan, Robert M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Outcomes research; Quality of life measurement; Shared decision making; Utility

Indexed keywords

AGED; CLINICAL MEDICINE; COMORBIDITY; COMPARATIVE STUDY; CONFERENCE PAPER; DENTAL CARE; DIAGNOSTIC ACCURACY; DISABILITY ADJUSTED LIFE YEAR; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MODEL; OUTCOMES RESEARCH; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; TREATMENT OUTCOME;

DECISION MAKING; DIAGNOSIS; HEALTH POLICY; HEALTH SERVICES RESEARCH; HUMANS; LIFE EXPECTANCY; MODELS, THEORETICAL; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; UNITED STATES;

EID: 0038288757     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023547632545     Document Type: Conference Paper

References (56)

1. Kaplan RM. Shared medical decision making: A new paradigm for behavioral medicine. Ann Behav Med 1999; 21(1): 3-11.
2. Ackoff RL. Systems thinking and thinking systems. Syst Dyn Rev 1994; 10(2-3): 175-188.
3. Carter RB. Descartes' Medical Philosophy: The Organic Solution to the Mind-Body Problem. Baltimore MD: Johns Hopkins University Press, 1988.
4. Checkland P. Systems theory and management thinking. Am Behav Sci 1994; 38(1): 75-91.
5. Ackoff RL, Gharajedaghi J. Reflections on systems and their models. Syst Res 1996; 13: 13-23.
6. Holman HR, Lorig KR. Patient education: Essential to good health care for patients with chronic arthritis (editorial, comment). Arthritis Rheum 1997; 40(8): 1371-1373.
7. Ware JE Jr, Bayliss MS, Rogers WH, Kosinski M, Tarlov AR. Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcomes Study. JAMA 1996; 276(13): 1039-1047.
8. Kaplan RM, The Ziggy theorem: Toward an outcomes-focused health psychology. Health Psychol 1994; 13(6): 451-460.
9. McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA 1993; 270(18): 2207-2212.
10. Coronary Primary Prevention Trial Group. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251(3): 351-364.
11. Golomb BA. Cholesterol and violence: Is there a connection? Ann Intern Med 1998; 128(6): 478-487.
12. Kaplan RM. Behavior as the central outcome in health care. Am Psychol 1990; 45: 1211-1220.
13. Fisher ES, Welch HG. Avoiding the unintended consequences of growth in medical care: How might more be worse? JAMA 1999; 281(5): 446-453.
14. Eddy DM. Clinical decision making: From theory to practice. Principles for making difficult decisions in difficult times. JAMA 1994; 271(22): 1792-1798.
15. Zir LM, Miller SW, Dinsmore RE, Gilbert JP, Harthorne JW. Interobserver variability in coronary angiography. Circulation 1976; 53(4): 627-632.
16. Detre KM, Wright E, Murphy ML, Takaro T. Observer agreement in evaluating coronary angiograms. Circulation 1975; 52(6): 979-986.
17. Schnitt SJ, Connolly JL, Tavassoli FA, et al. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 1992; 16(12): 1133-1143.
18. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: Cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. Br Med J (Clin Res Ed) 1997; 314(7094): 1580-1583.
19. Shiels C, Hutchinson A, Eccles M, Smoljanovic L. Accuracy and reliability of assessment of severity of illness before and after an educational intervention. J Eval Clin Pract 1996; 2(4): 265-271.
20. Unsworth CA, Thomas SA, Greenwood KM. Rehabilitation teams decisions on discharge housing for stroke patients. Arch Phys Med Rehabil 1995; 76(4): 331-340.
21. Kendall BS, Ronnett BM, Isacson C, et al. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Path 1998; 22(8): 1012-1019.
22. Sylvester PA, Wong NA, Warren BF, Ranson DL. Unacceptably high site variability in postmortem blood alcohol analysis. J Clin Path 1998; 51(3): 250-252.
23. Frierson HF Jr, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ, Boyd JC. Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 1995; 103(2): 195-198.
24. Drapé JL, Pessis E, Auleley GR, Chevrot A, Dougados M, Ayral X. Quantitative MR imaging evaluation of chondropathy in osteoarthritic knees. Radiology 1998; 208(1): 49-55.
25. Naitoh M, Yuasa H, Toyama M, Shiojima M, Ushida M, Iida H. Observer agreement in the detection of proximal caries with direct digital intraoral radiography. Oral Surg Oral Med Oral Path Oral Radiol Endod 1998; 85(1): 107-112.
26. Bright AS, Torpey B, Magid D, Codd T, McFarland EG. Reliability of radiographic evaluation for acromial morphology. Skeletal Radiol 1997; 26(12): 718-721.
27. Mussurakis S, Buckley DL, Coady AM, Turnbull LW, Horsman A. Observer variability in the interpretation of contrast enhanced MRI of the breast. Br J Radiol 1996; 69(827): 1009-1016.
28. Dahlström L, Lindvall AM. Assessment of temporomandibular joint disease by panoramic radiography: Reliability and validity in relation to tomography. Dentomaxillofaci Radiol 1996; 25(4): 197-201.
29. Jarvik JG, Haynor DR, Koepsell TD, Bronstein A, Ashley D, Deyo RA. Interreader reliability for a new classification of lumbar disk disease. Acad Radiol 1996; 3(7): 537-544.
30. Wennberg JE. The Dartmouth Atlas of Health Care in the United States. Hanover, NH: Trustees of Dartmouth College, 1998.
31. Fisher ES, Wennberg JE, Stukel TA, Sharp SM. Hospital Readmission Rates for Cohorts of Medicare Beneficiaries in Boston and New Haven. New England J Med 1994; 331(15); 989-995.
32. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
33. Kaplan RM, Anderson JP. The general health policy model: An integrated approach. In: Spilker B (ed), Quality of Life and Pharmacoeconomics in Clinical Trials. New York: Raven, 1996; 309-322.
34. Kaplan RM, Ganiats TG, Sieber WJ, Anderson JP. The Quality of Well-Being Scale: Critical similarities and differences with SF-36. Int J Qual Health Care 1998; 10(6): 509-520.
35. Field MJ, Gold MR. Summarizing Population Health, Washington DC, Institute of Medicine, 1998.
36. Lopez AD, Murray CC. The global burden of disease, 1990-2020 (news). Nat Med 1998; 4(11): 1241-1243.
37. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. New Engl J Med 1993; 328(17): 1237-1243.
38. American Cancer Society. Cancer Facts and Figures-1999, Atlanta: American Cancer Society, 1999.
39. Eddy DM. Screening for breast cancer. Ann Int Med 1989; 111(5): 389-399.
40. Fletcher SW. Whither scientific deliberation in health policy recommendations? Alice in the Wonderland of breast-cancer screening. New Engl J Med 1997; 336(16): 1180-1183.
41. Black WC, Welch HG. Screening for disease. Am J Roentgenol 1997; 168(1): 3-11.
42. Welch HG, Black WC. Using autopsy series to estimate the disease 'reservoir' for ductal carcinoma in situ of the breast: How much more breast cancer can we find? Ann Intern Med 1997; 127(11): 1023-1028.
43. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999; 49(1): 8-31.
44. Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA. Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992; 147(3 Pt 2): 815-816.
45. Smith DS, Catalona WJ. The nature of prostate cancer detected through prostate specific antigen based screening. J Urol 1994; 152(5 Pt 2): 1732-1736.
46. Kaplan RM. Breast cancer screening: When to begin? In: Blechman AE, Brownell KD (eds), Behavioral Medicine and Women: A Comprehensive Handbook, New York: Guilford Publications, 1998; 213-220.
47. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK. Cancer incidence and mortality, 1973-1995: A report card for the U.S. Cancer 1998; 82(6): 1197-1207.
48. Middleton RG. Prostate cancer: Are we screening and treating too much? (Editorial, comment). Ann Intern Med 1997; 126(6): 465-467.
49. (a) Coley CM, Barry MJ, Fleming C, Fahs MC, Mulley AG. Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians. Ann Intern Med 1997; 126(6): 468-479;
50. (b) Coley CM, Barry MJ, Fleming C, Mulley AG. Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians. Ann Intern Med 1997; 126(5): 394-406.
51. Optenberg SA, Thompson IM. Economics of screening for carcinoma of the prostate. Urol Clin North Am 1997; 17(4): 719-737.
52. Fowler FJ Jr, Barry MJ, Lu-Yao G, Wasson JH, Bin L. Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol 1996; 14(8): 2258-2265.
53. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA 1993; 269(20): 2650-2658.
54. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS. Screening for prostate cancer. A decision analytic view. JAMA 1994; 272(10): 773-780.
55. Fisher B. Cancer surgery: A commentary. Cancer Treat Rep 1984; 68(1): 31-41.
56. Frosch D, Kaplan RM. Shared medical decision making. Am J Prev Med 1999; 17(4): 285-294.